Molecular Pathology

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...

Fierce Healthcare (5/2, Sweeney) reports on a Medscape survey finding that among oncologists, about 70% “believe genetic testing is very important or extremely important to oncology, but 55% also say genomic testing is overpromoted.” One...

Dr. Heritage is widely recognized for his work in the development of informatics systems for drug and performance chemical discovery, translational and personalized medicine, and pharmaceutical product development. San Francisco, CA, February...

Inspirata has just released new mobile and Web-based versions of “Crosswalk Insight: Oncology™,” a knowledge visualization platform that enables users to easily navigate through tumor images and the associated molecular pathways, targeted...

XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, will co-present a session with the University of Chicago on collaborative diagnostic workflows at the Cambridge Healthtech...

Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com.  It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More...